Information Provided By:
Fly News Breaks for August 3, 2015
INCY
Aug 3, 2015 | 08:55 EDT
Leerink raised its price target for Incyte to $125 saying its survey of 49 U.S. hematologists indicated Jakafi has blockbuster potential in polycythemia vera. The firm keeps an Outperform rating on the stock.
News For INCY From the Last 2 Days
There are no results for your query INCY